Precision Medicine Group

Precision Medicine Group operates with the discipline of precision medicine as its foundation, bringing together targeted expertise to propel drug development and access. The organization consists of a global team of 3,500 experts operating across two main groups: Precision for Medicine, which provides biomarker-driven research and development, and Precision AQ, which delivers commercialization services supporting life science organizations from product launch through maturity. Its services span clinical development, laboratory services, commercial consulting, health economics and outcomes research, market access, and marketing.

The organization engages with data through specialized capabilities to accelerate drug development, advance manufacturing, and elevate commercial success. Its work touches machine learning through data products, analytics, and validation processes that incorporate machine-learning-generated results, supported by cross-functional collaboration between data engineering, machine learning, and software engineering teams.

The open roles indicate that the teams being built include senior research scientists focused on real-world evidence and health economic modelling, as well as product analysts supporting healthcare data products. These positions span different seniorities and work arrangements, including remote roles located in the United States as well as onsite positions based in London, United Kingdom.